That's crucial, due to the fact that the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and work. In other words, we have to understand how these proteins fold if we desire a drug to work. Historically, this has actually been a trial-and-error process (tech stocks). Now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much simpler to produce drugs that do what they're created to do. This was a breakthrough almost no one observed. But it's going to have extensive implications for treating disease. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be a lot of financial investment opportunities in this space, too. Shifting subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown 2021 predictions). That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be surprised if it pulled back possibly substantially prior to going greater - artificial intelligence. I've been covering bitcoin for a long time now. Among the first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I entitled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were primarily informing readers. However that's not the big concern any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a relied on 170-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. jeff brown latest prediction. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are many great personal business on the edge of striking the public markets And I have actually been working on a brand-new method for you to invest even prior to these companies go public.
This chance has actually been building over the last few years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the information. Go right here to book your spot for totally free.
Emma Walsh here, handling editor of the Journal. Regular Diary readers know that tech isn't our normal beat (genetic sequencer stock jeff brown). And when it pertains to tech investing, we leave it to the specialists. The good news is, we have numerous such experts in our Rolodex. Our coworker Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing professionals we understand (jeff brown latest prediction). In truth, he had numerous triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big image and forecast what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and much more. These patterns are experiencing rapid growth and producing extraordinary opportunities for investors. I desire to make certain all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see coming in the next 12 months Our new 5G (fifth-generation) wireless networks are a subject I have actually been covering for years now. diplomatic relations. But in spite of what numerous readers might believe, this is a pattern that's just getting going. Although the COVID-19 pandemic interfered with supply chains in 2015, a remarkable 250 million 5G-enabled gadgets were still offered.
And all of this ultimately led to Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (tech stock). Losing two months of manufacturing and sales truly affects the number of 5G gadgets are offered in the calendar year. When you think about all of that, selling 250 million systems is amazing. More significantly, the delays brought on by the pandemic developed a lots of pent-up need. And that need is now going to be pushed into 2021. In reality, I predict that more than 500 million 5G devices will be shipped in 2021 - self-driving cars. And that's not my only 5G prediction When I have actually talked about 5G in the past, I have actually described its three different stages.
In Phase 2, 5G devices go on sale. 5G phones and other items start to reach consumers. And in Stage Three, 5G services begin to be offered (jeff brown prediction for 2021). That's when we begin to see applications working on 5G networks. Think about things like enormous multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will begin Phase 3 by this summer season. This starts something of a virtuous cycle: The majority of people do not really appreciate the technology. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That leads to more 5G apps being developed. In truth, 5G is going to open a suite of extraordinary applications: self-driving vehicles, the Internet of Things, robotic surgery, and more. All of these technologies need 5G. The financial investment chances going forward will be massive. Stepping far from 5G, the next important technology I predict in 2021 is CRISPR genetic editing. CRISPR represents "clustered regularly interspaced short palindromic repeat." It's a mouthful. But it is among the most amazing advancements in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software.
The program can crash or not work correctly. CRISPR uses a similar concept however with our hereditary code. "Typos" in our genome can result in disease. CRISPR can fix these "typos." For years, CRISPR was mostly a specific niche technology that wasn't well comprehended. And during that time, there were actually only 3 companies operating in this area. However things are changing. CRISPR is no longer simply theoretical. We're seeing actual outcomes. We're treating diseases and seeing that this innovation simply works. And as an outcome, a "2nd crop" of early-stage CRISPR business is going public and providing unbelievable returns. This entire market is effectively a greenfield chance.
There's space for many companies to exist in this space. jeff brown genetic sequencer stock. And there will be more. That's my forecast for CRISPR in 2021. I forecast that two or three more hereditary editing companies will hold their IPOs. Sticking to biotechnology, we are seeing remarkable things taking place at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its most current Alpha, Fold software can precisely anticipate the folding of a protein based exclusively on its amino acid sequence with 92. 4% accuracy. That is very important because the way a protein in the human body folds figures out if a pharmaceutical will be able to bind to that protein and be effective.
Historically, this has been a trial-and-error procedure. Today, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to create drugs that do what they're developed to do. And here's my next forecast. I forecast that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one but a number of drug treatments produced utilizing this innovation. This was one of those breakthroughs that practically no one saw. However it's going to have profound implications for curing disease. And, naturally, there will be a lot of investment opportunities in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be surprised if it drew back possibly significantly prior to going higher. I've been covering bitcoin for a very long time now. One of the very first research study reports I ever released was on bitcoin - legacy report prediction. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my suggestion. However at the time of that initial suggestion, I titled my report, "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time.
But no one is asking that concern any longer. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. diplomatic relations. Mass, Mutual is a 150-year-old organization. So think about that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and declares the details depends on date since February 2021, however we might not independently validate this claim. Offered Jeff Brown's past, he likely has a significant net worth, however we can't hammer down an accurate figure at this minute. Brown is best understood for his sage-like capability to pick winning technology stocks. He spent more than 25 years researching innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience provides him an excellent perspective on the marketplace. He's always on the hunt for new opportunities, and he shares much of his best picks in the Near Future Report.
That's high praise, but it's not ridiculously reasoned. Brown has an outstanding reputation as a stock-picker, and he effectively forecasted a few of the most significant economic occasions of the past 20 years. Although he does not appear to release his picks to the general public, the service's success is a direct indication of Brown's stock-picking prowess. No one on Wall Street gets it right every time, however Jeff Brown's precise predictions have made him legions of devoted fans. That states a lot about his ability. The Near Future Report is published by Brownstone Research study, a popular financial research study publisher. Brownstone Research offers numerous research services with a wide range of expertises - jeff brown top biotech stock 2021.
The company is likewise affiliated with Bonner & Partners, another well-respected research publisher - black sea. On its site, Brownstone says its mission is to provide retail financiers with professional-grade research study: "For too long, the very best investment research has not been readily available to private financiers. It has been normally booked for investment banks, hedge funds, personal equity, and high-net-worth clients. jeff brown 1 biotech. The mission of Brownstone Research study is to make that sort of exclusive research available to any financiers aiming to get an edge in the marketplaces. The goal is simple to deliver unique and rewarding investment research study found nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also serves as the company's Chief Investment Expert.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to offer its customers. After decades of constant success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a household name throughout many of America. If you know even a little bit about the market, you understand that he has a credibility as a King Midas of sorts. united states. Everything he touches turns to gold! Jeff is aware of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge job.
In reality, Brown believes S.A.V. future report. could be "the biggest pattern of the 2020s, and he's not alone. Have a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be weding two innovative technologies: expert system and electrical cars. Musk hopes the mix will assist him establish the very first fully-autonomous, self-driving cars ever. It's nothing except the vehicle market's Holy Grail. As you understand, electrical cars and self-driving car stocks have actually been huge this year, but the Wall Street maker has approved buzz without much concrete result. Regardless of a drastic increase in competition over the previous few years, Brown still thinks Musk has the finest possibility of putting all of it together.
tech might be the magic string that connects all of it together. S.A.V. stands for Shared Autonomous Vehicle, and it might be the future of transport. Generally, this technology would enable you to lease your automobile as an autonomous, self-driving taxi when you're not utilizing it. You just leave the cars and truck and press a button on an app that informs the automobile to "join the fleet." Next thing you know, you're relaxing on your couch while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a large portion of the profits. It sounds crazy, but it could be closed than you believe.